Marvelta Suspension

Marvelta Suspension

Marvelta Suspension

ANTIULCERANTS: Sodium Alginate & Potassium Bicarbonate

Indication

Treatment of symptoms of gastro-oesophageal reflux, such as acid regurgitation, heartburn and indigestion (related to reflux), for example, following meals or during pregnancy or in patients with symptoms related to reflux esophagitis.

Contraindication

Sodium Alginate and Potassium Bicarbonate is contraindicated in patients with known hypersensitivity to these.

Dosage & Administration

Adults and children over 12 years: 5-10 ml (1-2 teaspoonful) after meals and at bedtime. Children 2-12 years: 2.5-5 ml (2  -1 teaspoonful) after meals and at bedtime.

Side Effect

In addition to the desired effect of the drug, some side effects may appear such as: nausea, constipation, diarrhea or headache.

Precaution

Marvelta should be prescribed with caution in patients with renal impairment and congestive cardiac failure.

Use in Pregnancy and LactationMarvelta can be given in pregnant and lactating women.

Drug Interaction

If you are taking other medicines concomitantly, or have just completed another drug treatment, inform your physician in order to prevent hazards or inefficacy arising from drug interactions.

Presentation

Each PET Bottle containing 200 ml of suspension.